We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+25.2%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$26.1M
AUM Growth
+$11M
Cap. Flow
+$7.16M
Cap. Flow %
27.42%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$7.16M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.58B
$26M 99.63%
5,254,788
+1,450,000
+38% +$7.16M
CORV
2
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$97K 0.37%
250,000

Similar funds

Summer Road's Q1 2020 Portfolio in Review

As of Q1 2020, Summer Road held 2 positions worth $26.1M, up 73% from $15.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summer Road deployed $7.16M of net new capital in Q1 2020, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Summer Road added most to Ocular Therapeutix in Q1 2020, an estimated $7.16M increase.
  • Summer Road's ten largest holdings make up 100% of its $26.1M portfolio in Q1 2020.
  • Summer Road opened 0 new positions and closed 0 in Q1 2020.
  • Summer Road's portfolio value rose 73% quarter-over-quarter to $26.1M.

Based on Summer Road's 13F filing for Q1 2020, filed 14 May 2020.